The estimated Net Worth of Gert L. Perlhagen is at least $108 millió dollars as of 14 March 2017. Gert Perlhagen owns over 125,000 units of NovoCure Ltd stock worth over $105,533,750 and over the last 9 years Gert sold NVCR stock worth over $2,503,331.
Gert has made over 3 trades of the NovoCure Ltd stock since 2016, according to the Form 4 filled with the SEC. Most recently Gert bought 125,000 units of NVCR stock worth $866,250 on 14 March 2017.
The largest trade Gert's ever made was selling 676,576 units of NovoCure Ltd stock on 5 August 2016 worth over $1,251,666. On average, Gert trades about 211,165 units every 32 days since 2016. As of 14 March 2017 Gert still owns at least 6,125,000 units of NovoCure Ltd stock.
You can see the complete history of Gert Perlhagen stock trades at the bottom of the page.
Gert's mailing address filed with the SEC is C/O NOVOCURE INC., 20 VALLEY STREAM PKWY, SUITE 300, MALVERN, PA, 19355.
Over the last 9 years, insiders at NovoCure Ltd have traded over $237,132,855 worth of NovoCure Ltd stock and bought 164,174 units worth $2,198,429 . The most active insiders traders include Asaf Danziger, William Fwfd Ventures Fund ... és Michael J. Ambrogi. On average, NovoCure Ltd executives and independent directors trade stock every 7 days with the average trade being worth of $853,350. The most recent stock trade was executed by Ashley Cordova on 2 August 2024, trading 688 units of NVCR stock currently worth $13,856.
we are a commercial-stage oncology company developing a novel, proprietary therapy called tumor treating fields, or ttfields, for the treatment of solid tumor cancers. we count on the contributions of our talented team members who are committed to improving the lives of cancer patients. here at novocure, cancer patients and their families are – and have always been – at the core of our mission. we expect our colleagues to excel, and in return, we invest in their professional growth and personal well-being. we seek high performers who thrive in fast-paced environments and are inspired by making a difference in cancer care. we offer employment opportunities in the u.s., europe and asia.
NovoCure Ltd executives and other stock owners filed with the SEC include: